Do the chitosan nanoparticles really augment the drugs' transdermal fluxes : ending the debate using meta-analysis

INTRODUCTION: Transdermal delivery has been extensively investigated as a successful alternative to the oral and parenteral routes of administration. The use of polymeric nanoparticles as drug delivery systems through this route has always been controversial. The use of meta-analyses is a useful quantitative means to decide upon the efficiency of this type of vehicles transporting drugs through the skin.

AREAS COVERED: In this meta-analysis study, polymeric nanoparticles were quantitatively compared to conventional formulations in order to investigate the feasibility of using these particles in transdermal delivery. Natural versus synthetic polymeric sub-groups were also contrasted to determine the most efficient class for transdermal drug enhancement.

EXPERT OPINION: Meta-analyses are gaining ground in the drug delivery field as they can exploit the mines of the literature and pick up by statistical evidence the superior formulations administered through several routes of administration. This is the first study that utilized the transdermal fluxes as the meta-analysis study effect and could prove the superiority of natural polymeric nanoparticles in transdermal delivery. In our opinion, there is paucity in research work regarding this type of nanocarriers, specifically on chitosan nanoparticles. More studies are warranted for full exploitation of its benefits.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Expert opinion on drug delivery - 21(2024), 2 vom: 10. Feb., Seite 325-335

Sprache:

Englisch

Beteiligte Personen:

Hathout, Rania M [VerfasserIn]
Ishak, Rania A H [VerfasserIn]
Shakshak, Doaa H [VerfasserIn]

Links:

Volltext

Themen:

9012-76-4
Chitosan
Drug delivery
Journal Article
Meta-Analysis
Nanoparticles
Pharmaceutical Preparations
Polymers
Review
Transdermal

Anmerkungen:

Date Completed 08.03.2024

Date Revised 08.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1080/17425247.2024.2317935

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368295761